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The purposes  of the  present  study have been  to  explore  the  possibility of 
producing a  strongly active fibrinolytic system in the circulating blood of rab- 
bits by intravenous injections of streptokinase and to observe its effect on arti- 
ficially induced intravascular clots. 
In developing  the  study,  a  number  of quantitative  estimations  have  been 
made  pertaining  to  the  streptococcal  fibrinolytic  system  as  it  occurs  in 
rabbit's blood. The determinations have included streptokinase  and plasmino- 
gen levels, streptokinase-activated plasmin (SK-plasmin), serum inhibitor (anti- 
plasmin), fibrinogen, and acid soluble N. Measurements have been made before, 
during, and after the intravenous injection and protracted infusion of solutions, 
containing SK. 
These findings have  been  applied  to  the  development  of a  method  for the 
lysis of intravascular  clots by creating an effective lyric system in the general 
circulation through the intravenous use of SK. 
Materials and Methods 
Streptococcal Coneentrate.--Streptokinase (SK) and streptococcal desoxyribonuclease (SD) 
were together contained in partially purified concentrates as a dry, sterile powder which also 
contained sodium chloride and phosphate buffer.  1 Two preparations  were used, lot 37A and 
73A. The SK-SD titers  per vial, as measured by the methods developed by Christensen  (1) 
were 75,000 SK--770 SD and 80,000 SK---47,000 SD respectively. 37A had 100 units of SK 
per gamma of N, while 73A had 51 units of SK per gamma of N. 
Inasmuch as SK was the principal enzyme under consideration, and because the results to 
be described were not observed  when  the streptokinase-activated  proteolytic  system  was 
specifically inhibited,  the concentrates that were employed will be described in terms of their 
content of SK without special consideration of other contained substances except their possible 
significance for toxicity.  The preparations  of SK were brought to the desired volume in 
5 per cent glucose. When high concentrations of the preparation  were used and the resulting 
* This study was supported  through a contract with the Medical Research and Develop- 
ment Board of the Office of the Surgeon General of the U. S. Army. 
1 The streptococcal concentrates were supplied by Lederle Laboratories Division, American 
Cyanamid Company, Pearl River, N. Y., under the trade name of varidase. 
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solution was in consequence hypertonic owing to the presence of large amounts of buffer salts 
the solutions were made isotonic by dialyzing against a  measured volume of distilled water 
Assay Methods.--Methods for the assay of SK and plasminogen (1), as well as of serum 
inhibitor (antifibrinolysin) (2-5) depend upon the lysis of standard clots within a given per; 
of time (1-5). For obvious reasons, the standard clot must be stable and as reprodudbte 
possible. Since the reagents available for these assays were not in a pure state, it was necessa 
to modify techniques to afford carefully standardized conditions. In order to insure the 
producibility of the results, as well as their accuracy, dilutions as closely spaced as 0.05 
units were employed rather than twofold serial dilutions as previously described. Other~" 
the SK assay was performed as described. 
In the plasminogen assay, plasma was used for the sample rather than sera because a sm~ 
amount of plasminogen was found to be adsorbed on the fibrin clot during the process 
coagulation. The amount of SK was increased about 40 times (4000 units of low inlfibito 
SK  (6)  per tube), in order to minimize the action of the inhibitors normally present in tb 
reagents and sample. The plasminogen assay was further modified by plotting the clot lysis 
time and the reciprocal of the dilution of the sample on log-log paper. One unit of plasminogen 
was defined as the dilution lysing in 30 minutes, as interpolated on the lysis time curve. When 
the  slope  of  the  curve was  markedly  abnormal,  it  usually indicated  deterioration of  the 
fibrinogen. 
Because of the fact that measurements of serum inhibitor presented special problems the 
method is presented in detail.  Serum inhibitor titrations were performed by analyzing the 
residual activity of a standard solution of fibrinolysin after prolonged incubation with various 
dilutions of serum or purified inhibitor (2-4). One unit of fibrinolysin (plasmin), according to 
Loomis (7)  and Seegers (3), was defined in terms of a  clot lysis time of approximately 120 
seconds. Because the unit of SK used in this study was based upon the lysis of a standard clot 
in 10 minutes, at 35°C., by SK-activated plasmin (1), it proved desirable to use a  10 minute 
end-point at 35°C. for inhibitor titrations. Using bovine fibrinolysin,  2 it was found that one- 
half as much of the material was needed to lyse a standard clot in 10 minutes as in 5 minutes. 
Therefore, a unit was defined as the amount of fibrinolytic activity required to lyse a standard 
clot in 5 minutes, i.e.; 1 ml. of a 0.1 per cent fibrin clot at 35°C. in saline phosphate buffer at 
pH 7.5.  When logarithmic dilutions of rabbit and human sera, as well as of purified serum 
inhibitor were incubated for 1 hour with 1 unit of bovine fibrinolysin at 28°C.  and the re- 
sulting mixture incubated at 35°C. with the standard clot, the logarithm of the time of lysis 
of  the  standard  clot was inversely proportional to  the  logarithm of  the reciprocal of  the 
inhibitor dilution in this range. A unit of serum inhibitor was defined as the quantity of in- 
hibitor which will inactivate 50 per cent of the fibrinolysin in 1 ml. of a  standard solution 
containing 1 unit at 28°C., at pH 7.5. In practice, the clot lysis time and the reciprocal of the 
dilution of the inhibitor were plotted on log-log paper as in the plasminogen assay, and a 
lysis time of 10 minutes, as indicated by interpolation on the lysis time curve, was considered 
to contain 1 unit of inhibitor. 
Cdlection of Plasma and Sera.--When plasma was desired it was obtained from an ear vein 
on the side opposite to the site of insertion of the caunula. About 30 rag. of sodium citrate pet 
ml. of plasma was used as the anticoagulant. Calculated amounts of a 48 per cent solution of 
sodium citrate were used to prevent clotting of the whole blood as the sample was taken. 
However, it was found to be necessary to dilute the concentrated plasma further to prevent 
clot formation. This was effected by bringing the plasma to a  final dilution of 1:2 with an 
aqueous solution of 1.8 per cent sodium citrate. All samples were stored at -20°C. and sub- 
sequent dilution for assay performed in an ice bath. Since excessive blood loss is poorly toler- 
The bovine fibrinolysin was supplied by Dr. E. C. Loomis of the Research Laboratories, 
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ated by rabbits under stress, the number of the samples and amount of each were kept to a 
iifinimum. 
"~l'he coagulation  lime  was  determined  by  a  modification of the  Lee-White method  (8). 
['Pen drops of undiluted venous blood ,sTere allowed to flow from the vein of a  siliconed  3 ear 
".°~/7~ a  150  )<  750 ram. test tube in about 30 seconds. A stopwatch was started with the first 
~615. The normal coagulation time for rabbits by this method was found to be about 5 minutes. 
'?'L-"  .  ...... 
~I'h~. lys~s l*me *n vztro, (representmg the SK plasmm) was determined on the same sample 
.i11':1 was calculated from the same initial time as the coagulation time because SK-activated 
~smin appears to attack fibrinogen and fibrin at the same rate (9). Furthermore, the coagu- 
-IY  .  ion time varied widely in rabbits, following the injection of SK, and therefore did not seem 
,,?lsropriate as a  base line for the lysis time.  Complete lysis of the clot usually occurred in 
.~out  12  minutes with a  normally active fibrinolytic system.  lc  Fibrinogen  Assays.--Classical  methods (10,  11)  for the assay of fibrinogen by the deter- 
"I  .  mnation  of  clottable  nitrogen  were  modified  to  prevent  the  SK-activated  plasmin  from 
attacking the fibrmogen and fibrin m the plasma as the assayswere being performed. Each step 
was performed in  the cold, with ice-cold reagents.  Crystalline  (soy  bean)  trypsin inhibitor 
was added since it has been shown to inhibit the SK-plasmin system (12).  Preliminary ex- 
periments in this laboratory have indicated that  trypsin inhibitor gave excellent protection 
against clot lysis at 35°C. for more than 5 hours when equivalent quantities of SK-plasmin 
and soy bean inhibitor (1)  were used. 
Approximately five times this amount of trypsin inhibitor was added to the solutions treed 
in the determination. Citrated rabbit plasma was diluted 1:25 in isotonic saline in a  siliconed 
test tube, clotted with thrombin, 4 and allowed to remain in the icebox for 1 hour. At the end 
of this time, the clot was broken up by rotation of the tube and subsequent centrifugation. 
The  supernatant  was  then decanted and  the formed clot washed with distilled water and 
centrifugation five times. Trypsin inhibitor was not added for the final wash. The fibrin was 
dissolved in 1 N NaOH and incubated for 3 hours at 56°C. The solution was neutralized and 
the  "tyrosine" was  then determined colorimetrically on  the incubation mixture,  using  tri- 
sodium phosphate in  the  place  of  sodium  carbonate  (13).  Trisodium  phosphate was  used 
because  of  the  increased  sensitivity with  this  reagent  (14).  The  fibrin  concentration  was 
calculated from standard curves in which "tyrosine" color was plotted against dried, purified 
fibrin  as well  as  fibrin  nitrogen. 
Acid-Soluble  Nitrogen.--Acid-soluble  nitrogen was determined on 8 per cent trichloracetic 
acid  filtrates by micro-Kjeldahl and  nesslerization. 
Urine.--Samples were collected by indwelling Foley catheters and were analyzed for SK 
and SD by the methods previously referred to. 
Infusion Apparatus.--The  micro-infusion apparatus used in these studies is illustrated in 
Text-fig.  1. The flow of liquid was regulated primarily by a  stainless steel micrometer that 
applied appropriate pressure on rubber tubing between two three-way stopcocks. A separatory 
funnel was elevated by a  pulley  approximately  7.5  feet above the micrometer to  obtain a 
suitable pressure head for large volumes of fluid, and a  size 24 needle with the bevel cut off, 
was used to obtain a  small, uniform drop. A  30 ml. syringe was mounted in the system to 
facilitate the withdrawal or addition of limited amounts  of fluid.  Intermediate hydrostatic 
pressures,  for very fine adjustments of the flow, were obtained  by  raising or lowering the 
separatory funnel above or below the height already mentioned. 
The handle of the 30 ml. syringe was filled with mercury to provide a pressure system for a 
small volume of fluid.  Small bore polyethylene tubing was used wherever feasible. The in- 
3 2 per cent solution of Dow Coming silicone, DC 200, in ether. 
4 Thrombin,  topical  (bovine origin),  Parke,  Davis  &  Company,  Detroit. 452  LYSIS  OF  INTRAVASCULAR  BLOOD  CLOTS  BY  STREPTOKINASE 
TExT-FIO.  1.  Micro-infusion apparatus  for intravenous introduction of SK. 
A--polyethylene  tube  from  separatory  funnel;  B--adapter  to  connect  polyethylene 
tubing;  M--micrometer;  N--drip  needle  (against  black  background)  in  drip  apparatus; 
R--polyethylene tube to rabbit  ear and cannula. 
fusion apparatus reproducibly delivered as much as 20.0 mh per minute in a  continuous stream 
through the needle, or less than 0.02 ml. per minute at about 1 drop every minute. 
The same micrometer setting did not give exactly the same rate  of flow  on different oc- 
casions, but the rate could be reproduced  exactly by using the number of  drops per minute 
as the criterion for minor changes in the micrometer setting. ALAN  J.  JOHNSON  AND  WILLIAMS  S.  TILLETT  453 
The SK infusion was given at a rate of 0.31 ml. a minute for most of the experiments in 
order to standardize any increase in the rabbit blood volume. Hematocrit determinations on 
control rabbits showed that hemodilution was not severe  at this rate, even though the experi- 
ment was continued for many hours. 
EXPER IM-I~NTAL 
Determina[ion of the Streptococcal Fibrinolytic  System in Rabbits 
The studies were made on plasma and serum obtained from rabbits before, 
during, and after injections of the enzyme concentrates. The methods of injec- 
tion ranged from the rapid introduction of large amounts in a few minutes to 
as long as 24 hours of continuous infusion.  Since the  method  of  protracted 
intravenous infusion has yielded the most satisfactory results, most of the data 
contained in this article were obtained from the latter type of experiments. 
Plasminogen.--Using the method previously described, with different batches 
of low inhibitor SK, approximately 300 to 350 units per ml. has been found to 
represent the average content of plasminogen in the plasma of normal rabbits. 
(This method has shown about 7000 units in the plasma of normal man.) 
The data for plasminogen recorded in Text-fig. 2 were obtained from seriaI 
determinations made during  the  intravenous  infusion of  SK over a  24  hour 
period. It can be noted that the level of plasminogen progressively decreased 
until it reached a value of 30 units per ml. of plasma approximately 24 hours 
after the beginning of the infusion. 
According to current theory (12), this was due to the progressive conversion 
of plasminogen  to  plasmin  by SK.  Indeed,  the  level of plasminogen  in  the 
plasma has been found to be one of the most dependable and sensitive biochemi- 
cal measures of the streptococcal fibrinolytic system in ~ivo. 
On the basis of a  large number of experimental results comparable to that 
shown in Text-fig. 2 it appears likely that the rate of formation of plasminogen 
in the rabbit is insufficient to keep pace with its activation by SK. 
Additional studies to be presented subsequently (Text-fig. 4) have also indi- 
cated that the restoration of the plasminogen to the preinjection level usually 
occurs within 24 hours after the infusion of SK has ceased. 
SK-Plasmin.--The  presence  of  an  active  lytic  system  in  the  circulating 
blood during  and  after the  injection of SK was  demonstrated,  as  indicated 
under Materials and Methods, by the lysis of samples of undiluted whole blood 
taken during the experimental period and allowed both to clot spontaneously 
in a test tube and to undergo lysis subsequently (Text-figs. 3 and 5). 
The effect of the SK-plasmin on the coagulation time seemed to be independ- 
ent of the amount of SK infused but varied, within 1 to 2 minutes, according 
to the lot number of SK used.  Unlike trypsin (15-17) and papain  (15), how- 
ever, the coagulation time was not uniformly shortened in over 350 samples 
from 48 rabbits inasmuch as the mean of the postinjection coagulation  time 
(5.3  minutes)  was  about  the  same as  the preinjection coagulation  time  (5.2 
minutes). On the other hand, the lysis of these clots was the principal criterion 454  LYSIS OF INTRAVASCULAR BLOOD CLOTS BY STREPTOKINASE 
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for the presence of SK-plasmin and the time of lysis was the best indication of 
the amount of SK-plasmin. The mean lysis time of the samples referred to above 
was 12.3 minutes. In contrast to the data of Macfarlane with dilute plasma (5), 
complete lysis of the undilute,  clotted whole blood occurred in  less  than 30 
minutes, or it did not occur at all. The difference did not appear to be due to 
the presence of the red cells but is thought to be due to the concentration of 
inhibitor in the undiluted blood together with the very mild proteolytic system 
developed by the SK in vivo. 
During  the infusion of adequate SK doses, an active lyric system was ob- 
sewed to be present within 30 minutes following the beginning of the experi- 
ment. It remained present for periods of time ranging from 1 hour to 20 hours, 
depending upon the concentration of SK and the duration of the infusion as 
well  as  the  amount of activatable plasminogen  and  the  level of the  serum 
inhibitor. 
In Text-fig. 3, for example, it can be seen that the active lyric system en- 
dured for approximately 20 hours during a period of infusion of 1,800,000 units 
of SK for 24 hours. The fact that an active lyric system was not present at 24 
hours although free SK was found in the plasma  at  this  time  (Text-fig. 3), 
would  seem  to  indicate  that  the  very  low  plasminogen  mentioned  above 
was  probably responsible for its absence. 
In the experiments recorded in Text-fig. 5, a single injection of 900,000 units 
of SK was given over a period of 10 minutes. The die-away curve of SK plasmin 
can be readily visualized as the clot-lysis time extended to its maximum of 30 
minutes, at 3 hours  postinjection. This die-away can also be seen in the free 
SK  (Text-fig. 5),  and its consequences mirrored by the  concordant fall and 
subsequent  rise  in  the  plasminogen,  fibrinogen,  and  serum  inhibitor  levels 
(Text-fig. 4). 
In spite of the interplay of a number of different factors, the large amounts 
of SK that were introduced intravenously appear to have created an effective 
lytic system for individual rabbits in which the special factors, plasminogen 
and  inhibitors,  varied.  These findings will  again  be discussed  in  connection 
with the actual lysis of the intravascular clots to be described. 
Free  SK.--In  general,  very small  amounts  of SK  were detectable in  the 
plasma during or after the infusion of SK in vivo (Text-figs. 3 and 5). Inactiva- 
tion,  inhibition,  or removal of SK  from  the  blood occurs rather  promptly. 
Striking evidence of this is shown in Text-fig. 5 where only trace amounts of 
SK were detectable in the rabbit plasma 30 minutes after the injection of 900,- 
000 units of SK. When SK was added to rabbit whole blood and plasma respec- 
tively, in amounts comparable to the calculated in vivo blood levels, assay of 
the samples accounted for about 10 per cent of the SK. It appears, therefore, 
that  while a  considerable loss of SK activity occurs in  vitro,  a  significantly 
greater loss occurs in vivo. This suggests  that  another mechanism  or mecha- 
nisms may play a part in the in vivo loss of SK activity. The mechanism does ALAN  J.  JOHNSON  AND  WILLIAMS  S.  TILLETT  457 
not appear to be urinary excretion since SK was very rarely found in the urine 
(Text-figs. 3 and 5). It is not known whether this was associated with the very 
low plasma levels noted above, or due to a specific renal block. 
Serum Inkibitor.--The mean serum inhibitor  in rabbits as measured by the 
method previously described, was about 500 units per ml. with a  range of 250 
to  750  units  per  ml.  Although  a  mild  decrease in  the  serum  inhibitor was 
usually noted during and immediately following  the injection of SK, the in- 
hibitor level rapidly returned  to normal  within  24 hours  (Text-fig. 4).  The 
striking  changes  observed by Lewis and  Ferguson  (18)  on  the  injection  of 
fibrinolysin and staphylokinase in dogs were not observed in these experiments. 
Further work on this and other inhibitors to SK and SK-plasmin is in progress. 
F~rinogen.NIn view of the fact that the active SK fibrinolytic system at- 
tacks fibrinogen at about the same rate as fibrin in vitro (9), determinations 
have been made of changes in the amount of circulating fibrinogen occurring 
during infusions of SK (Text-figs. 2 and 4). The rate of reduction in fibrinogen 
was very slow in spite of the constant infusion of SK and the presence of an 
active fibri~olytic system. These findings suggest that the rate of fibrinogenoly- 
sis in vivo may be slower than anticipated from the in vitro studies, or that the 
formation of fibrinogen by the animal nearly paralleled its destruction. In some 
of the animals, the level of fibrinogen rose considerably above normal 24 hours 
after the injection of SK (Text-fig. 4). It was not known whether this was due 
to a  specific response to fibrinogenolysis or a  non-specific response to the in- 
jection of foreign protein. 
Acid-Soluble  N.--Moderately consistent elevations (15  to 30 rag.  per cent) 
have been found in the level of the plasma acid-soluble nitrogen following the 
infusion of SK.  This has been interpreted as further evidence of proteolysis 
induced in v/vo, by the SK fibrinolytic system, and was thought to be due to 
the products of proteolytic digestion. 
From Text-fig. 2 it can be seen that the acid-soluble N rose about 15 mg. per 
cent during the period of infusion with SK. It is of interest that this occurred 
in the face of a mild hemodilution effected by the infusion. From this and other 
experiments, it was concluded that the rise in acid-soluble N  seemed to corre- 
late with the apparent lytic activity of the system, and was not present after 
the infusion of SK in two instances when an elevation in serum inhibitor pre- 
vented the formation of an active lytic system. The rise usually started about 
3 to 6 hours after the beginning of the infusion and returned to normal within 
12 hours after the infusion was terminated. 
Lysis of Previously Prepared Intravascular Clots in Vivo by the 
Systemic  Administration of Streptokinase 
A standard blood clot about 10 to 20 ram. long was formed in the medial or 
marginal ear veins of gray chinchilla rabbits by means of a  sclerosing agent, 
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Through and through suture ligatures were used to isolate a segment  of the vein after a 
single intravenous injection of nembutal had been given. The blood was then extracted from 
the isolated segment with a 26 Huber point hypodermic needle and the segment washed with 
0.5 per cent procaine in saline or with saline alone. 0.1 to 0.05 ml. of a 5 per cent solution of 
sodium morrhuate in 2 per cent benzyl alcohol  5  was introduced through the needle, allowed to 
remain in contact with the vein wall at least 5 minutes, and the vein segment was then washed 
free of the sodium morrhuate with saline. The needle was withdrawn, the suture ligatures cut, 
and the venous flow aUowed to continue uninterrupted. A firm occluding clot was formed in 
less than 15 minutes (Fig. 1 a). 
Patency or obstruction of the vein was determined by transillumination of the ear with a 
200 watt microscope illuminator, after the validity of this method had been established in 
preliminary experiments by dissection of the vein following the application of morrhuate, and 
the lysis of in vivo clots, respectively. 
Gross and histological examinations of the segments of vein made at varying 
intervals following the  introduction of sodium  morrhuate  revealed complete 
obstruction by the freshly formed clot within 15 minutes.  Eventual fibrosis of 
the area followed after  2  to 4  weeks in all the control  animals.  In  contrast, 
spontaneous  recanalization of a  significant percentage of clots occurred with 
all  other  agents  tested, including thrombin,  hypertonic glucose, and  sodium 
psylliate,  e as well as trauma to the walls of the veins. 
No anesthetic was required to keep the rabbits quiet during the infusion period. They were 
placed in a conventional rabbit box (painted white)  without the top. A domestic type 250 
watt infrared light was placed about 4 feet away from the box and the very mild beam directed 
over the box proved to be effective in keeping the animals in the box. Small quantities of food 
and water were given to many of them during the long infusion periods. 
SK-SD was injected intravenously in the ear contralateral to  the one  con- 
taining the clot. The total dosage of SK per rabbit varied from 410,000 units to 
2,080,000 units. The preparations of concentrate containing SK also contained 
100 to 2,000,000 units of streptodornase (SD). The findings with respect to in- 
travenously injected SD are not  included in  this  article but  will be  given  in 
a  separate  communication.  The  average  effective  dose  of  SK  proved  to  be 
40,000  units  per  kilo  per  hour,  although  in  some  instances  the  animals  de- 
veloped a  lytic system  with  15,000  units per kilo per hour. 
The  methods  of  injection  of  SK  were:  single  massive  injections,  smaller 
intermittent  injections,  and  finally,  the  most  efficient  and  easily  controlled 
technique,  continuous infusion,  which  was  employed in about  80 per cent of 
the  experiments.  The  average  duration  of  the  continuous  and  intermittent 
infusions was 8 hours, with a  range of 6 to 12 hours. In order to insure a  firm, 
well consolidated clot the beginning of the infusion was  deferred for 6  to  72 
s Sodium morrhuate 5 per cent with benzyl alcohol 2 per cent, G. D. Searle and Company, 
Chicago. 
s  Sodium psylliate  (sylnasol)  in benzyl alcohol 2 per cent, G. D. Searle  and Company, 
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hours after the clot had formed. Figs. 1 a  and  1 b are photographs of the ear of 
a  rabbit  which was treated  in the following manner: 
A  clot (Fig.  1 a)  was formed in the marginal vein  7 of the left ear with 0.05  cc. sodium 
morrhuate and a cannula inserted in the marginal vein of the opposite ear. 8 hours later, the 
SK infusion was started at a dosage level of 25,000 units SK per kilo per hour.  1 hour later, 
samples were taken and allowed to clot and lyse in test tubes. They did not lyse completely, 
however, and the dosage was elevated to 50,000 units per kilo per hour. At this level, an active 
fibrinolytic system was established and complete lysis of the samples occurred. 4 hours and 
30 minutes after the infusion was begun, the clot in the ear vein appeared lysed, and subse- 
quently remained lysed. The infusion was discontinued 2½ hours later. The total quantity of 
SK given was 880,000 units. 
TABLE I 
Lysls of Intravascular  Clots in Rabbits as Result of Intravenous Infusion of SK 
Lot No.  No. of 
of SK  rabbits 
37A  1  6 
73A 
Total 
19 
25 
Complete lysis effected 
Lysis persisted  Clot re-formed 
4 
(1 ACTH) 
15 
19 
2 
(2 ACTtt) 
2 
(1 ACTH) 
Survived  Died* 
3  3 
(3 ACTH) 
14  5 
(I ACTH) 
17  8 
Average dose SK: 35,000  to 40,000  units per kilo per hour. 
Mean total dose: 7.8 X  106 units. Range: 4.1  X  105 to 20.8  X  10  ~. 
Average duration of infusion 8 hours. Range: 6 to 12 hours. 
Infusion began 6 to 72 hours after the clot had formed. 
* See text for details. 
A  number of these experiments  are summarized in Table I. 
Following liquefaction of  the  clot,  lysis was  permanent  in  19 of 23  animals 
(Table I).  No re-formation of the  thrombus  occurred  for a  period of observa- 
tion of at least 6 months among the animals that survived (Table I). An analy- 
sis of the duration of the SK infusion in these experiments revealed two general 
principles.  (a)  It was found  to be necessary to maintain  an active lyric system 
for 3  to  7 hours  in  the circulating blood of these animals in order to lyse their 
clots.  (b)  3  to 4  additional hours of an active lyric system were required to pre- 
7 The large veins at the base of the ear were generally chosen for clot formation, but were 
found to be very difficult to photograph. It was felt that clot lysis in a large vein represented a 
more significant test  system  because  a  thrombus in a  large vein with very few tributaries 
simulated closely a thrombus in a human vein. As might be predicted, the lysis time of a clot 
in the small, distal ear vein with its many tributaries was considerably shorter than the lysis 
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vent re-formation of the clots. Thus, 6  to 12 hours of constant infusion with 
SK produced clot lysis when the infusion was accompanied by demonstrable  acti- 
vation of the SK-plasmin.  The previously clotted vein remained patent for the 
life of the animal if these conditions obtained. 
The clot re-formed at the original site in four of the animals (Table I). Three 
of them received ACTH,  8 however, and comment on them will be made subse- 
quently in connection with the administration of ACTH. Re-formation of the 
clot in the fourth animal of this group probably occurred because the intravas- 
cular lytic system was not maintained for a  sufficiently long time. In this in- 
stance, progressively increasing doses of SK failed to activate the SK-plasmin 
in vivo for longer than 2½ hours. Samples of plasma from this animal,  subse- 
quently tested, were observed to inhibit SK-plasmin markedly in vitro. 
Two experiments are included in Table I  wherein no clot lysis was effected. 
No SK-plasmin was demonstrable in either of these at any time despite the 
administration of massive doses of SK. Samples of plasma from these animals 
also exhibited striking inhibition of SK-plasmin when tested in vitro. 
It is significant that the minimum requirements for clot lysis were not satis- 
fied in  the animal with  high  inhibitor whose clot re-formed, and in  the  two 
whose clots did not lyse. 
Inasmuch as clot re-formation was prevented by continuing the infusion for 
3 to 4 hours after the clot appeared to be lysed, it was of interest to determine 
whether the duration of this infusion could be shortened and an ancillary anti- 
coagulant used in its place. 
In four instances, this was done, and heparin  9 was given after the SK infusion 
was terminated and the lyric system was no longer present. In one preliminary 
experiment the heparin was  given for only 6  hours and a  clot promptly re- 
formed in the same place after the heparin was discontinued. A tendency toward 
clot re-formation was also evident after heparin was given for as long as  14 
hours. Less tendency toward clot re-formation occurred in two instances when 
heparin administration was prolonged (24 hours or more). 
These experiments seemed to indicate that the mechanism for the prevention 
of clot re-formation by SK was not that of an anticoagulant,  although pro- 
longed use of an anticoagulant could be substituted for it. Additional studies 
are in progress. 
Toxicity.--Because  of the unusually large amounts of SK required to effect 
clot lysis, in vivo, over half a gram of protein was present in the partially puri- 
fied enzyme concentrates injected intravenously in  each experiment.  On  the 
basis of present information it has been estimated that these preparations were 
less than 10 per cent pure SK (19). As a result of the large amount of contami- 
nating protein, some of it in the form of other enzymes, the toxicity of the SK 
itself has been very difficult to evaluate. 
ACTH (adrenocorticotropin), The Armour Laboratories, Armour and Company, Chicago. 
9 Heparin,  Connaught  Medical  Research  Laboratories,  Toronto,  Canada. ALAN  ~. ~OI-INSON AND  WILLIAMS  S. TILLETT  461 
It was our impression that ACTH minimized the secondary toxic effects of 
these injected concentrates. ACTH was administered to 4 of the 25 animals in 
this series (Table I), and all the rabbits treated with ACTH and SK survived. 
Eight of the 21 animals not receiving ACTH died within 48 hours after the in- 
fusion had  been  started  (Table I), although none died after this time. There 
was no  evidence to  indicate that ACTH  interfered with  the formation of an 
active lytic system in these or other animals so treated. 
In the 8 animals that died, special interest has centered around whether or 
not  pulmonary  infarction occurred.  Detailed gross  examination  of the  lungs 
has failed to reveal any evidence of pulmonary infarction that may have arisen 
from the partial liquefaction of the clot with subsequent release of a  fibrinous 
embolus. 
On examination of the dead animals, it was observed that 2 had extensive  preexisting 
coccidiosis of the liver and lungs, respectively, with abscess formation.  In one rabbit, trauma 
to the psoas muscle resulted from the struggling of the animal under partial anesthesia.  In 
two other instances,  marked damage was found in the psoas as a result of the loca/effect of 
intraperitoneally injected metrazol. 19 (The latter was used as an analeptic agent, and was 
injected after the anesthesia was terminated and at least 6 hours before the SK infusion was 
started.) In all 3  animals there was  evidence  of massive  hemorrhage  into the previously 
traumatized area. 
It appears highly probable that when the fibrinolytic system was developed 
intravenously there ensued increased bleeding at sites where small blood ves- 
sels had been injured. This type of bleeding has also been observed when  the 
urethra has been traumatized by the insertion of a  catheter into the bladder 
to collect urine for assays of SK and SD excreted in the urine. 
In the 3 remaining rabbits which died, no significant contributing cause, such as coccidi- 
osis or hemorrhage,  was found and death is ascribed to an as yet, undetermined effect of the 
streptococcal concentrates.  In this connection,  lot 37A of SK-SD was found to be far more 
toxic than lot 73A even though lot 37A was twice as "pure" as lot 73A as measured by units 
of SK per gamma of N. This was further emphasized by the fact that the only animals that 
survived infusion  with 37A had also received ACTH, while only 1 of the 14 animals that 
received lot 73A and survived had also been given ACTH. 
The subject of the toxicity of the preparations is being given detailed study 
with respect to which one or more of the several different enzymes or extrane- 
ous materials may be of special significance. 
Previous mention has been made of the antitoxic effect of ACTH. ACTH has 
proved to be of limited use in these experiments, however, because after lysis 
had occurred a  clot re-formed at the original site in 3 of the 4 animals receiving 
ACTH  (Table I) whereas re-formation of the clot occurred in only one of the 
19  animals not  receiving  ACTH.  In  one  of  the  animals  in  which  a  clot  re- 
formed,  the  first  dose  of  ACTH  was  not  administered  until  10  hours  after 
lysis of the clot had been accomplished. These observations are in accord with 
10 Metrazol (pentamethylenterazol), Bilhuber-Knoll Corp., Orange,  N. J. 462  LYSIS  OF  INTRAVASCULAR BLOOD CLOTS BY  STP,-EPTOKINASE 
the work of Cosgriff in man (20-21)  wherein he  has  shown  that  there is an 
increase in the coagulability of the blood in patients treated with ACTH and 
cortisone, together with an increased incidence of thromboembolic phenomena. 
SD~fMARY 
I.  Based upon quantitative estimations of the factors that promote or retard 
the development and activity of the  streptococcal  fibrinolytic phenomenon, 
an active lytic system was developed within the  circulating blood stream of 
rabbits following the intravenous infusion of streptokinase. During the infusion 
of adequate doses of SK, an active lyric system was observed to be present 
within 30  minutes following the beginning of the  experiment and remained 
present for periods of time ranging from I  to 20 hours depending primarily 
upon the concentration of SK and the duration of the infusion. Some of the 
biochemical changes accompanying the lyric system in vivo were: (a) a striking 
fall in the plasminogen; (b) a moderate fall in the serum inhibitor and the fibrin- 
ogen; and, (c) a rise in the acid-soluble nitrogen. These changes were usually 
self-terminating within 24 hours following the infusion of SK. In earlier studies 
similar trends were observed in the chest fluid of patients with hemothorax 
and empyema treated locally with streptokinase (22). 
2.  Intravascular clots,  induced artificially by local  applications of sodium 
morrhuate within the ear vein of the rabbits, were observed to liquefy and dis- 
appear in 23 of 25 rabbits during the intravenous infusion of SK into the oppo- 
site ear. 
The average quantity of SK necessary to effect an active lyric system was 
found to be about 40,000 units per kilo per hour. 
The clot in the ear vein was observed to be lysed completely in periods of 
time ranging from 3 to 7 hours after the infusion of SK was begun. Maintenance 
of an active lytic system for 3 to 4 additional hours was required to prevent 
re-formation of the clots at the original site. In 3 of 4 rabbits in which clots 
did reform, ACTH had been given to combat the toxic effects of the strepto- 
coccal concentrates. 
3.  The toxicity of the unusually large dose of the streptococcal concentrates, 
containing measured amounts of SK, along with other identifiable and unknown 
substances, was considerable, inasmuch as 8 animals eventually died. No evi- 
dence of pulmonary infarction was observed at autopsy. The administration of 
ACTH appeared to prevent a fatal outcome in at least 3 of the rabbits. Further 
studies of toxicity are in progress. 
The authors wish to acknowledge the capable technical assistance of Mrs. Edmund Ham- 
burger and Miss Leila Hirsch. 
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EXPLANATION  OF PLATE 45 
The photographs were made by John GoeUer, 
FIG. 1  a. The photograph of the ear of rabbit I was made 5 hours after  the clot 
had been formed and 3 hours before  the SK infusion  was started.  X  21/~. 
FIG. 1 b,  The photograph of  the  ear  of  rabbit  1 was made about 48 hours after  the 
photograph in I  a,  and about 41 hours after  the clot  had been lysed.  X  2~. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 95  PLATE  45 
(Johnson and Tillett:  Lysis of intravascular blood clots by streptokinase) 